CN102731512B - 一种鲁拉西酮中间体及鲁拉西酮的制备方法 - Google Patents
一种鲁拉西酮中间体及鲁拉西酮的制备方法 Download PDFInfo
- Publication number
- CN102731512B CN102731512B CN201110091528.0A CN201110091528A CN102731512B CN 102731512 B CN102731512 B CN 102731512B CN 201110091528 A CN201110091528 A CN 201110091528A CN 102731512 B CN102731512 B CN 102731512B
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- lurasidone
- wormwood
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PQXKDMSYBGKCJA-CVTJIBDQSA-N lurasidone Chemical compound C1=CC=C2C(N3CCN(CC3)C[C@@H]3CCCC[C@H]3CN3C(=O)[C@@H]4[C@H]5CC[C@H](C5)[C@@H]4C3=O)=NSC2=C1 PQXKDMSYBGKCJA-CVTJIBDQSA-N 0.000 title claims abstract description 24
- 229960001432 lurasidone Drugs 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 52
- 238000010992 reflux Methods 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000002253 acid Substances 0.000 claims abstract description 8
- 239000011230 binding agent Substances 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 19
- 235000015320 potassium carbonate Nutrition 0.000 claims description 19
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 17
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 9
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 6
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 4
- AJSHDAOMUKXVDC-UHFFFAOYSA-N butan-1-amine;sulfuric acid Chemical compound CCCC[NH3+].OS([O-])(=O)=O AJSHDAOMUKXVDC-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 23
- 238000004440 column chromatography Methods 0.000 abstract description 5
- 230000035484 reaction time Effects 0.000 abstract description 3
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 150000003892 tartrate salts Chemical class 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 60
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 239000002994 raw material Substances 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 238000000227 grinding Methods 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229940095064 tartrate Drugs 0.000 description 4
- YSSSPARMOAYJTE-UHFFFAOYSA-N dibenzo-18-crown-6 Chemical compound O1CCOCCOC2=CC=CC=C2OCCOCCOC2=CC=CC=C21 YSSSPARMOAYJTE-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 101150049660 DRD2 gene Proteins 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- -1 compound sodium carbonate Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
碳酸钾平均粒径 | 式(Ⅱ)化合物收率 | 式(Ⅱ)化合物熔点 |
350 | 40% | 220~225℃ |
245 | 55% | 222~226℃ |
220 | 65% | 223~227℃ |
198 | 75% | 228~230℃ |
165 | 76% | 228.5~230.5℃ |
74 | 78% | 228~229℃ |
碳酸钾平均粒径 | 式(Ⅰ)-消旋体收率 | 式(Ⅰ)-消旋体熔点 |
350 | 70% | 215~217℃ |
245 | 75% | 216~218℃ |
220 | 80% | 218~220℃ |
198 | 91% | 225~227℃ |
165 | 92% | 226~228℃ |
74 | 92.5% | 225.5~228℃ |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110091528.0A CN102731512B (zh) | 2011-04-12 | 2011-04-12 | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110091528.0A CN102731512B (zh) | 2011-04-12 | 2011-04-12 | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102731512A CN102731512A (zh) | 2012-10-17 |
CN102731512B true CN102731512B (zh) | 2015-04-22 |
Family
ID=46987889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110091528.0A Expired - Fee Related CN102731512B (zh) | 2011-04-12 | 2011-04-12 | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102731512B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014064714A2 (en) * | 2012-10-22 | 2014-05-01 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for preparation of lurasidone hydrochloride |
CN102936243B (zh) * | 2012-11-16 | 2015-08-05 | 上海伯倚化工科技有限公司 | 一种鲁拉西酮的合成方法 |
CN103864774B (zh) * | 2012-12-14 | 2016-09-28 | 成都弘达药业有限公司 | 一种鲁拉西酮的制备方法 |
CN103207246B (zh) * | 2012-12-21 | 2017-10-10 | 北京万全德众医药生物技术有限公司 | 一种用液相色谱法分离测定鲁拉西酮及其光学异构体的方法 |
ITMI20130262A1 (it) * | 2013-02-22 | 2014-08-23 | Edmond Pharma Srl | Procedimento per la preparazione di lurasidone cloridrato |
EP3207041B1 (en) * | 2014-10-14 | 2019-12-04 | Jubilant Generics Limited (Formerly Jubilant Life Sciences Division) | An improved process for the preparation of lurasidone hydrochloride |
EP3242876A4 (en) | 2015-01-08 | 2019-01-02 | Piramal Enterprises Limited | An improved process for the preparation of lurasidone and its intermediate |
CN106146486A (zh) * | 2015-04-21 | 2016-11-23 | 上海医药集团股份有限公司 | 一种制备高纯度高收率鲁拉西酮的方法 |
EP3394042A1 (en) * | 2015-12-25 | 2018-10-31 | Shionogi & Co., Ltd | Process and intermediates for preparation of thiazine derivatives |
CN106632358A (zh) * | 2016-10-31 | 2017-05-10 | 北京万全德众医药生物技术有限公司 | 盐酸鲁拉西酮中间体的一种制备方法 |
CN106946872A (zh) * | 2017-03-20 | 2017-07-14 | 常州工程职业技术学院 | 一种制备鲁拉西酮关键中间体的方法 |
CN113185507B (zh) * | 2020-01-14 | 2022-07-26 | 扬子江药业集团南京海陵药业有限公司 | 一种鲁拉西酮制备方法 |
CN115950695B (zh) * | 2021-10-09 | 2023-07-28 | 北京阳光诺和药物研究股份有限公司 | 一种制备鲁拉西酮基毒杂质的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0464846A1 (en) * | 1990-07-06 | 1992-01-08 | Sumitomo Pharmaceuticals Company, Limited | Imide derivatives, and their production and use |
WO1996014297A1 (fr) * | 1994-11-04 | 1996-05-17 | Sumitomo Pharmaceuticals Company, Limited | Nouveaux derives de lactame |
CN101146539A (zh) * | 2005-03-01 | 2008-03-19 | 辉瑞有限公司 | Pde7抑制剂用于治疗神经性疼痛的用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4708012B2 (ja) * | 2004-12-15 | 2011-06-22 | 大日本住友製薬株式会社 | 第四級アンモニウム塩の製造法 |
-
2011
- 2011-04-12 CN CN201110091528.0A patent/CN102731512B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0464846A1 (en) * | 1990-07-06 | 1992-01-08 | Sumitomo Pharmaceuticals Company, Limited | Imide derivatives, and their production and use |
WO1996014297A1 (fr) * | 1994-11-04 | 1996-05-17 | Sumitomo Pharmaceuticals Company, Limited | Nouveaux derives de lactame |
CN101146539A (zh) * | 2005-03-01 | 2008-03-19 | 辉瑞有限公司 | Pde7抑制剂用于治疗神经性疼痛的用途 |
Non-Patent Citations (2)
Title |
---|
Charles M. Marson,等.Enantioselective Syntheses of trans-3,4-Difluoropyrrolidines and Investigation of Their Applications in Catalytic Asymmetric Synthesis.《Journal of Organic Chemistry》.2005,第70卷(第24期),第9771-9779页. * |
Charles M. Marson,等.Synthesis of (3S,3S’,4S,4S’)-1,1’-ethylene-di-pyrrolidine-3,3’,4,4’-tetraol and related diamino diols: donor-acceptor hydrogen-bonding motifs of the C2 symmetric 3,4-dihydroxypyrrolidine unit.《Tetrahedron: Asymmetry》.2005,第16卷(第16期),第2799-2809页. * |
Also Published As
Publication number | Publication date |
---|---|
CN102731512A (zh) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102731512B (zh) | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 | |
CN109020881A (zh) | 一种阿帕替尼的制备方法 | |
CN101717368A (zh) | 一种微波条件下制备咪唑类离子液体的方法及其工艺 | |
CN103570633B (zh) | 吉非替尼的制备方法 | |
CN103724259A (zh) | 一种索拉非尼的合成方法 | |
CN104356092A (zh) | 沃替西汀的制备方法 | |
CN104262264B (zh) | 一种盐酸乌拉地尔的制备工艺 | |
CN102558097A (zh) | 一种改进的雷诺嗪合成方法 | |
CN105566162A (zh) | 利匹韦林中间体的制备工艺 | |
CN101654416B (zh) | N-[3-硝基-4-甲基-苯基]-4-醛基-苯甲酰胺及其制备方法以及其衍生物的制备方法 | |
CN104744530B (zh) | 一种天麻衍生物晶型及其制备方法、制剂与应用 | |
CN105884746B (zh) | 氟马替尼的合成方法 | |
CN106674084A (zh) | 一种2‑异丙基氧基‑5‑甲基‑4‑(哌啶‑4‑基)苯胺二盐酸盐的制备方法 | |
CN104130146B (zh) | (4s)-3,6,9-三氮杂-3,6,9-三(羧甲基)-4-(4-乙氧基苄基)十一烷二酸的制备方法 | |
CN103304524A (zh) | 一种雷美替胺中间体的制备方法 | |
CN102659629A (zh) | 化合物及其在制备埃罗替尼中的用途 | |
CN102731368B (zh) | 一种5,5-二氟-3-取代哌啶衍生物的制备方法 | |
CN105175355B (zh) | 一种2-氰基吩噻嗪的制备方法 | |
CN114262320A (zh) | 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法 | |
CN105272921A (zh) | 一种制备Ceritinib的方法及其中间体化合物 | |
CN103073485B (zh) | 一种丁酸氯维地平的制备方法 | |
CN102070513A (zh) | 1-叔丁氧羰基-4-哌啶酮的合成方法 | |
CN102199146A (zh) | 制备n-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺的方法 | |
CN106883185B (zh) | 一种4-氯-2-三氟甲基嘧啶的制备方法 | |
CN103130628B (zh) | 一种萘丁美酮的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee after: Tianjin Institute of Pharmaceutical Research Co.,Ltd. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200518 Address after: 300462 No.101, Xinye 8th Street, economic and Technological Development Zone, Binhai New Area, Tianjin Patentee after: TIANJIN TAIPU PHARMACEUTICAL Co.,Ltd. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 |